Literature DB >> 35325287

Predictive factors for postoperative visual acuity improvement with ICL-V4c for ultrahigh myopia above - 10 D.

Xiong Ying1, Yu Li1, Fengju Zhang2.   

Abstract

PURPOSE: The purpose of this study is to evaluate the predictive factors for postoperative visual acuity improvement (PVAI) in subjects who underwent phakic intraocular lens implantation with a central hole (ICL-V4c) for ultrahigh myopia above - 10 D.
METHODS: This was a retrospective study. Eyes with ultrahigh myopia above - 10 D undergoing ICL-V4c implantation were studied. Univariable linear regression models were used to assess the association between PVAI and preoperative parameters. Myopic maculopathy was classified into 5 categories by fundus photography. After the 1-month follow-up, the PVAI was compared within different age and preoperative spherical degree groups.
RESULTS: This study included 726 eyes from 419 patients (111 men and 308 women), and the mean age, spherical refraction, and axial length were 28.67 ± 7.93 years, - 13.61 ± 3.44 D, and 28.59 ± 1.50 mm, respectively. At baseline, myopic maculopathy was classified (grades C0-C4) as follows: C0 was observed in 200 eyes (27.5%), C1 in 297 eyes (40.9%), C2 in 147 eyes (20.2%), C3 in 22 eyes (3.0%), and C4 in 60 eyes (8.3%). The PVAI was significantly negatively associated with age and positively associated with SD-pre(-Sph), but no significant association between myopic maculopathy classification and axial length was found. After 1 month, 417 eyes (57.4%) gained more than 1 line at BCVA, 250 eyes (34.4%) remained the same, and 59 eyes (8.13%) lost 1 line. The postoperative visual acuity of 52 eyes was improved by more than 3 lines, and 42.3% were grade C4.
CONCLUSIONS: The ICL performed well for the correction of ultrahigh myopia above - 10 D. Younger patients and those with a higher preoperative spherical degree had greater postoperative satisfaction. TRIAL REGISTRATION: Chinese Clinical Trial Registry (ChiCTR2000036335). Date of registration: 2020/8/22.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  ICL-V4c; Implantable Collamer lens; Myopic maculopathy; Ultrahigh myopia; Visual quality

Mesh:

Year:  2022        PMID: 35325287     DOI: 10.1007/s00417-022-05626-5

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.535


  6 in total

1.  International photographic classification and grading system for myopic maculopathy.

Authors:  Kyoko Ohno-Matsui; Ryo Kawasaki; Jost B Jonas; Chui Ming Gemmy Cheung; Seang-Mei Saw; Virginie J M Verhoeven; Caroline C W Klaver; Muka Moriyama; Kosei Shinohara; Yumiko Kawasaki; Mai Yamazaki; Stacy Meuer; Tatsuro Ishibashi; Miho Yasuda; Hidetoshi Yamashita; Akira Sugano; Jie Jin Wang; Paul Mitchell; Tien Yin Wong
Journal:  Am J Ophthalmol       Date:  2015-01-26       Impact factor: 5.258

2.  Dichoptic De-Masking Learning in Adults With Amblyopia and Its Mechanisms.

Authors:  Xiang-Yun Liu; Jun-Yun Zhang
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-07-01       Impact factor: 4.799

3.  Progression of myopic maculopathy after treatment of choroidal neovascularization.

Authors:  Cláudia L Farinha; Alda S Baltar; Sandrina G Nunes; João P Figueira; Isabel A Pires; Maria L Cachulo; Rufino M Silva
Journal:  Ophthalmologica       Date:  2014-03-22       Impact factor: 3.250

4.  Comparison of Implantable Collamer Lens Visian ICL V4 and ICL V4c for high myopia: A cohort study.

Authors:  Ying Tian; Hai-Bo Jiang; Jian Jiang; Dan Wen; Xiao-Bo Xia; Wei-Tao Song
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

Review 5.  Laser-assisted subepithelial keratectomy (LASEK) versus laser-assisted in-situ keratomileusis (LASIK) for correcting myopia.

Authors:  Jocelyn Kuryan; Anjum Cheema; Roy S Chuck
Journal:  Cochrane Database Syst Rev       Date:  2017-02-15

6.  Vector analysis of small incision lenticule extraction and toric implantable collamer lens implantation for astigmatism correction.

Authors:  Ting Wan; Houfa Yin; Zhiyi Wu; Yabo Yang
Journal:  Eur J Ophthalmol       Date:  2020-05-29       Impact factor: 2.597

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.